Suppr超能文献

应用临终需求纸牌游戏和基于正念的癌症康复计划以减轻晚期肺癌患者的负面情绪:一项随机对照试验

Application of the end-of-life demands card game and mindfulness-based cancer recovery program for reducing negative emotion in patients with advanced lung cancer: a randomized controlled trial.

作者信息

Luo Xian, Miao Xiaoju, Ding Nana, Fu Zhongmin, Wang Xiaowen, Li Yonghong

机构信息

Department of Nursing, Affiliated Hospital of Zunyi Medical University, Zunyi, China.

Department of Neurosurgery, Affiliated Hospital of Zunyi Medical University, Zunyi, China.

出版信息

Front Psychol. 2025 Mar 19;16:1476207. doi: 10.3389/fpsyg.2025.1476207. eCollection 2025.

Abstract

BACKGROUND

Lung cancer is the leading cause of cancer-related deaths globally and the most common type of cancer in China, posing significant health and socio-economic challenges. Despite the effectiveness of psychological interventions for death anxiety, discussions around death are often avoided in China due to cultural taboos and neglect of end-of-life care.

PURPOSE

This study aimed to explore the effectiveness of the self-designed end-of-life demands card game (ELDCG) and mindfulness-based cancer recovery program (MBCR) programs in alleviating death anxiety, anxiety, depression, and stress in patients with advanced lung cancer.

METHODS

This was a randomized, single anonymized study. We randomly assigned 77 patients into two groups: the intervention group (38 patients) and the control group (39 patients). Routine health promotion was implemented in the intervention group, along with the ELDCG combined with the MBCR program, while the control group only received routine health promotion. The intervention lasted for 6 weeks. The intervention group completed the ELDCG within the first week, and the MBCR was completed during the remaining 5 weeks. The primary outcome was the Templer's Death Anxiety Scale (T-DAS) score, and the secondary outcomes were the Hospital Anxiety and Depression Scale (HADS) score, the score on the Chinese version of the Perceived Stress Scale (CPSS), and frequency of selection in the ELDCG. The assessment results of these scales were collected both before the intervention began and after the 6-week intervention period. The frequency of card selections was recorded after the ELDCG.

RESULTS

After implementing the 6-week ELDCG and MBCR program, the intervention group showed significantly lower scores than the control group in death anxiety ( < 0.001), anxiety ( < 0.001), depression ( < 0.001), and stress ( < 0.001). The card with the highest selection frequency (13 times) was "I need the right to choose treatment options and understand the expected outcomes."

CONCLUSION

The ELDCG might assist patients in emotionally coming to terms with death, while the MBCR offered potential strategies for managing stress. Together, they seemed to alleviate death anxiety and negative emotions by addressing these psychological factors, which in turn improves patients' ability to manage their illness. This improvement not only enhances their quality of life but also helps prevent the unnecessary consumption of healthcare resources, thus alleviating some of the financial strain on the healthcare system. Future research should assess the long-term effects and explore broader applications for terminally ill patients.

CLINICAL TRIAL REGISTRATION

https://clinicaltrials.gov/, identifier ChiCTR2400081628.

摘要

背景

肺癌是全球癌症相关死亡的主要原因,也是中国最常见的癌症类型,带来了重大的健康和社会经济挑战。尽管心理干预对死亡焦虑有效,但在中国,由于文化禁忌和对临终关怀的忽视,围绕死亡的讨论往往被回避。

目的

本研究旨在探讨自行设计的临终需求纸牌游戏(ELDCG)和基于正念的癌症康复计划(MBCR)在缓解晚期肺癌患者的死亡焦虑、焦虑、抑郁和压力方面的效果。

方法

这是一项随机、单盲研究。我们将77例患者随机分为两组:干预组(38例患者)和对照组(39例患者)。干预组实施常规健康促进,同时采用ELDCG结合MBCR计划,而对照组仅接受常规健康促进。干预持续6周。干预组在第一周内完成ELDCG,其余5周完成MBCR。主要结局是坦普勒死亡焦虑量表(T-DAS)评分,次要结局是医院焦虑抑郁量表(HADS)评分、中文版感知压力量表(CPSS)评分以及ELDCG中的选择频率。这些量表的评估结果在干预开始前和6周干预期结束后均进行收集。ELDCG后记录纸牌选择频率。

结果

实施6周的ELDCG和MBCR计划后,干预组在死亡焦虑(<0.001)、焦虑(<0.001)、抑郁(<0.001)和压力(<0.001)方面的得分显著低于对照组。选择频率最高的纸牌(13次)是“我需要选择治疗方案并了解预期结果的权利”。

结论

ELDCG可能有助于患者在情感上接受死亡,而MBCR提供了应对压力的潜在策略。它们似乎通过解决这些心理因素来缓解死亡焦虑和负面情绪,进而提高患者管理疾病的能力。这种改善不仅提高了他们的生活质量,还有助于防止不必要的医疗资源消耗,从而减轻医疗系统的一些经济负担。未来的研究应评估长期效果,并探索对绝症患者更广泛的应用。

临床试验注册

https://clinicaltrials.gov/,标识符ChiCTR2400081628。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd09/11961935/d763b4eea660/fpsyg-16-1476207-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验